Syr-472/ Trelagliptin Succinate cas 1029877-94-8  (jerryzhang001@chembj.com) - Nanjing Bangnuo Biotechnology Co., Ltd.

Syr-472/ Trelagliptin Succinate cas 1029877-94-8  (jerryzhang001@chembj.com)

PRICE: 5 USD
Company:
Nanjing Bangnuo Biotechnology Co., Ltd.
Contact Person:
Jerry Zhang
Phone:
86-25-52198306


Product Description

Oral Safe and Super Pure 99% Dipeptidyl Peptidase IV Inhibitor SYR-472/ Trelagliptin Succinate CAS 1029877-94-8 for Treatment of Type 2 Diabetes

 

  1. Quick Detail:

 

Name: SYR-472

Other Name: SYR-472;Trelagliptin (succinate);SYR 472 succinate;SYR472 succinate;SYR-472 succinate;Trelagliptin Succinate (SYR-472);SYR 111472 succinate;Trelagliptin succinat

Purity : 99%

CAS : 1029877-94-8

MF: C18H20FN5O2.C4H6O4

MW: 196.248

Place of Origin:  China

Brand Name: NJBNSteroid

Usage: SYR-472 is an oral dipeptidyl peptidase IV inhibitor originated by Takeda. It is in phase III clinical trials for the treatment of type 2 diabetes.

Description:

TRELAGLIPTIN (SYR-472)

Trelagliptin is a novel DPP-4 inhibitor that is being developed by Takeda. In contrast to alogliplitin, which is once a day, trelagliptin is a once-weekly oral agent which should provide patients with a convenient therapeutic alternative and has the potential to improve compliance. Takeda has commenced Phase III trials of trelagliptin in Japan for the treatment of Type 2 diabetes.

 

Other products
Join Free